Cegedim buys pharma intelligence firm Nomi
The Nomi Group provides databases of healthcare professionals, customer relationship management, market research and prescription studies to pharma companies in Sweden, Norway, Finland and Denmark. It generated revenue of around 60 million Swedish Krona (£4.7m) in 2008.
Nomi’s Sabine Lindstrom will continue to manage market research, while regional managing director Peter Norrgard becomes Nordic regional director for the newly combined company’s CRM activities.
Cegedim Dendrite CEO Laurent Labrune said Nomi’s local expertise and market share in the Nordic region would help the company offer a more complete range of services.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments